Exploring pharmacy and drug policy concerns.
Li
Edward C
EC
D000970:Antineoplastic Agents / Q000009:adverse effects; D006801:Humans; D007958:Leukocyte Count; D008329:Managed Care Programs; D008495:Medical Oncology / Q000592:standards / Q000639:trends; D009504:Neutrophils; D010594:Pharmacies; D057766:Policy; D011050:Policy Making; D011358:Product Surveillance, Postmarketing / Q000379:methods / Q000592:standards / Q000639:trends; D018570:Risk Assessment; D012308:Risk Management; D014481:United States; D014486:United States Food and Drug Administration
D000970:Antineoplastic Agents